Maryland

Go Back to Map ←

Maryland’s bioscience industry is an innovative and growing component of the overall U.S. economy. With a track record of generating high-quality jobs and steady growth, the bioscience industry has been a consistent engine for our economy and a key strength during past economic recessions. American innovation in bioscience helps support state and local communities in a variety of ways ranging from job creation, construction, tax revenues, and other economic impact values.

Driven by small-company innovators, the bioscience industry has also mobilized in an unprecedented manner to address the global COVID-19 pandemic, while continuing to develop other life-saving and life-enhancing products and services for the U.S. and the world. America’s bioscience industry as an innovator and economic driver has never been more important, both for our health and our economic stability.

Total Number of Facilities in Maryland 53
Jobs Directly Supported by the Industry in Maryland 49945
Annual Average Wage
$140498
Total Clinical Trials
872
Dollar Amount Invested in Clinical Trials
$323.4 Million
Clinical Trial Participants
19317
Total Clinical Trial Economic Impact
$845.7 Million
View State PDF

View Facilities By District

View Facilities by District
District Total Facilities in District View Facilities in District
MD01 1

Bayer (H)
MD02 2

BioTech Primer, Inc (O)

Intra-Cellular Therapies, Inc. (H)
MD03 3

DSM (H)

Meridian Medical Technologies (H)

Plasma Protein Therapeutics Association (O)
MD04 1

NextCure (H)
MD06 17

Altimmune, Inc. (H)

BioVeris Corporation (H)

Emergent Biosolutions, Inc. (H)

Emergent Product Development Gaithersburg (H)

Frederick County Maryland, Office of Economic Development (O)

Leadiant Biosciences, Inc. (H)

Maryland Life Sciences (O)

Maryland Tech Council (O)

MaxCyte, Inc. (H)

Montgomery College Business, Science, Mathematics & Technology (O)

NexImmune, Inc. (H)

Novavax, Inc (H)

Pinkney Innovation Complex for Science & Technology (O)

Sirnaomics, Inc. (H)

Valneva USA, Inc. (H)

VLP Therapeutics (H)

Vtesse, Inc. (H)
MD07 4

Asklepion Pharmaceuticals, LLC (H)

Eisai Inc. (H)

Maryland Department of Business & Economic Development (O)

Rapafusyn Pharmaceuticals, Inc. (H)
MD08 25

American Gene Technologies International Inc. (H)

AnGes, Inc. (H)

BeneVir Biopharm (H)

BioHealth Innovation, Inc. (O)

BioMarker Strategies, LLC (H)

Creatv MicroTech, Inc. (H)

Cystic Fibrosis Foundation (O)

GlycoMimetics, Inc. (H)

Human Genome Sciences (H)

I-ACT for Children (O)

Immunomic Therapeutics, Inc (H)

MacroGenics, Inc. (H)

Maryland Department of Commerce (O)

Micromet, Inc (H)

Montgomery County Economic Development Corporation (O)

Neomics Pharmaceuticals LLC (H)

New Enterprise Associates (NEA) (O)

OncoImmune, Inc. (H)

REGENXBIO (H)

Sucampo Pharmaceuticals, Inc. (H)

Synthetic Biologics, Inc (H)

Thegreencell, Inc. (H)

United Therapeutics Corporation (H)

Unither Virology (H)

Viela Bio (H)